Association of Polygenic Risk Scores for Hearing Difficulty in Older Adults With Hearing Loss in Mid-Childhood and Midlife: A Population-Based Cross-sectional Study Within the Longitudinal Study of Australian Children.


Journal

JAMA otolaryngology-- head & neck surgery
ISSN: 2168-619X
Titre abrégé: JAMA Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 101589542

Informations de publication

Date de publication:
01 03 2023
Historique:
pmc-release: 26 01 2024
pubmed: 27 1 2023
medline: 14 3 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Although more than 200 genes have been associated with monogenic congenital hearing loss, the polygenic contribution to hearing decline across the life course remains largely unknown. To examine the association of polygenic risk scores (PRSs) for self-reported hearing difficulty among adults (40-69 years) with measured hearing and speech reception abilities in mid-childhood and early midlife. This was a population-based cross-sectional study nested within the Longitudinal Study of Australian Children that included 1608 children and 1642 adults. Pure tone audiometry, speech reception threshold against noise, and genetic data were evaluated. Linear and logistic regressions of PRSs were conducted for hearing outcomes. Study analysis was performed from March 1 to 31, 2022. Genotypes were generated from saliva or blood using global single-nucleotide polymorphisms array and PRSs derived from published genome-wide association studies of self-reported hearing difficulty (PRS1) and hearing aid use (PRS2). Hearing outcomes were continuous using the high Fletcher index (mean hearing threshold, 1, 2, and 4 kHz) and speech reception threshold (SRT); and dichotomized for bilateral hearing loss of more than 15 dB HL and abnormal SRT. Included in the study were 1608 children (mean [SD] age, 11.5 [0.5] years; 812 [50.5%] male children; 1365 [84.9%] European and 243[15.1%] non-European) and 1642 adults (mean [SD] age, 43.7 [5.1] years; 1442 [87.8%] female adults; 1430 [87.1%] European and 212 [12.9%] non-European individuals). In adults, both PRS1 and PRS2 were associated with hearing thresholds. For each SD increment in PRS1 and PRS2, hearing thresholds were 0.4 (95% CI, 0-0.8) decibel hearing level (dB HL) and 0.9 (95% CI, 0.5-1.2) dB HL higher on the high Fletcher index, respectively. Each SD increment in PRS increased the odds of adult hearing loss of more than 15 dB HL by 10% to 30% (OR for PRS1, 1.1; 95% CI, 1.0-1.3; OR for PRS2, 1.3; 95% CI, 1.1-1.5). Similar but attenuated patterns were noted in children (OR for PRS1, 1.1; 95% CI, 0.8-1.2; OR for PRS2, 1.2; 95% CI, 1.0-1.5). Both PRSs showed minimal evidence of associations with speech reception thresholds or abnormal SRT in children or adults. This population-based cross-sectional study of PRSs for self-reported hearing difficulty among adults found an association with hearing ability in mid-childhood. This adds to the evidence that age-related hearing loss begins as early as the first decade of life and that polygenic inheritance may play a role together with other environmental risk factors.

Identifiants

pubmed: 36701147
pii: 2800637
doi: 10.1001/jamaoto.2022.4466
pmc: PMC9880866
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

204-211

Auteurs

Jing Wang (J)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Katherine Lange (K)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Valerie Sung (V)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Center for Community Child Health, Royal Children's Hospital, Parkville, Victoria, Australia.

Angela Morgan (A)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Audiology and Speech Pathology, The University of Melbourne, Parkville, Victoria, Australia.
Speech Pathology Department, Royal Children's Hospital, Parkville, Victoria, Australia.

Richard Saffery (R)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Melissa Wake (M)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Department of Pediatrics and The Liggins Institute, The University of Auckland, Grafton, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH